Kristen Eisenman, MD

Instructor/Fellow, Pediatrics-Palliative Medicine


FacultyPhoto
Medical School
  • MD, University of Nebraska College of Medicine (2003)
Undergraduate School
  • BS, University of Nebraska–Lincoln (NE) (1999)
  • BA, University of Nebraska–Lincoln (NE) (1999)
Internship
  • University of Florida Program (2004)
Residency
  • University of Florida Program, Chief Resident, Pediatrics (2007)
Fellowships
  • University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology (2011)
Languages
English, French
Department
Pediatrics-Palliative Medicine

Recognitions

  • Fellow Travel Stipend, American Society of Pediatric Hematology Oncology (2010)
    Awarded for Oral Platform Presentation "Mer as a Potential Novel Therapeutic Target in Acute Myeloid Leukemia" given at ASPHO National Meeting, 2010

Publications

  • Eisenman, K, Hunger SP. F1000 Medicine review of Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes--A report From the Children's Oncology Group. Faculty of 1000 Medicine, 27 Jan 2012. http://f1000.com/13492976
  • Eisenman, K, Hunger SP. F1000 Medicine review of Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group. Faculty of 1000 Medicine, 21 June 2012. http://f1000.com/716547807
  • Eisenman, K*, Rogers, A*, Hunger SP. Chemotherapy of Childhood ALL. In Contemporary Management of Acute Lymphoblastic Leukemia. In press. *These authors contributed equally to this book chapter
  • Sherrick, A*, Eisenman, K*, McGranahan, A, Sather, S, Cannon, C, Martinson, H, Liang, X, DeRyckere, D, Keating, A, and Graham, D. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene. In press. *These authors contributed equally to this manuscript
  • Lee-Sherick AB, Eisenman KM, Sather S, McGranahan A, Armistead PM, McGary CS, Hunsucker SA, Schlegel J, Martinson H, Cannon C, Keating AK, Earp HS, Liang X, DeRyckere D, Graham DK. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene. 2013 Nov 14;32(46):5359-68. PubMed PMID: 23474756
  • Kesselheim JC, Atlas M, Adams D, Aygun B, Barfield R, Eisenman K, Fulbright J, Garvey K, Kersun L, Nageswara Rao A, Reilly A, Sharma M, Shereck E, Wang M, Watt T, Leavey P. Humanism and professionalism education for pediatric hematology-oncology fellows: A model for pediatric subspecialty training. Pediatr Blood Cancer. 2014 Oct 12. [Epub ahead of print] PubMed PMID: 25307425
  • Hunger S and Eisenman K: F1000Prime Recommendation of [Bhatia S et al., J Clin Oncol 2012, 30(17):2094-101]. In F1000Prime, 21 Jan 2013; DOI: 10.3410/f.717970149.793468896. F1000Prime.com/717970149#eval793468896
  • Hunger S and Eisenman K: F1000Prime Recommendation of [Vrooman LM et al., J Clin Oncol 2013, 31(9):1202-10]. In F1000Prime, 11 Apr 2013; DOI: 10.3410/f.717976584.793473866. F1000Prime.com/717976584#eval793473866
  • Hunger S and Eisenman K: F1000Prime Recommendation of [Burnett AK et al., J Clin Oncol 2013, 31(27):3360-8]. In F1000Prime, 21 Oct 2013; DOI: 10.3410/f.718074017.793485401. F1000Prime.com/718074017#eval793485401
  • Eisenman, K*, Rogers, A*, Hunger SP. Chemotherapy of Childhood ALL. In Contemporary Management of Acute Lymphoblastic Leukemia. In press. *These authors contributed equally to this book chapter.
  • Hunger S and Eisenman K: F1000Prime Recommendation of [Davila ML et al., Sci Transl Med 2014, 6(224):224ra25]. In F1000Prime, 30 Apr 2014; DOI: 10.3410/f.718283045.793494100. F1000Prime.com/718283045#eval793494100
  • Eisenman, K*, Rogers, A*, Hunger SP, Chemotherapy of Childhood ALL. In Contemporary Management of Acute Lymphoblastic Leukemia. In press. *These authors contributed equally to this book chapter.
  • Kesselheim J, Atlas M, Adams D, Aygun B, Barfield R, Eisenman K, Fulbright J, Kersun L, Nageswara Rao A, Sharma M, Shereck E, Wang M, Watt T, Leavey P. Humanism and Professionalism for Pediatric Hematology-Oncology Fellows (HP-PHO). MedEdPORTAL; Mon Nov 18 00:00:00 EST 2013. Available from: www.mededportal.org/publication/9607
  • Kesselheim JC, Atlas M, Adams D, Aygun B, Barfield R, Eisenman K, Fulbright J, Garvey K, Kersun L, Nageswara Rao A, Reilly A, Sharma M, Shereck E, Wang M, Watt T, Leavey P. Humanism and professionalism education for pediatric hematology-oncology fellows: A model for pediatric subspecialty training. Pediatr Blood Cancer. 2014 Oct 12. [Epub ahead of print] PubMed PMID: 25307425
  • Eisenman K, Rogers A, Hunger SP, Chemotherapy of childhood acute lymphoblastic leukemia and acute myeloid leukemia. In Contemporary Management of Acute Lymphoblastic Leukemia. Pullarkat V (ed). Jaypee Brothers Medical Publishers, New Dehli, 2014.
  • Rogers, A, Eisenman, K et al. Risk Factors for Central Line Associated Blood Stream Infections in Children with Acute Myelogenous Leukemia: A Single Institution Report. Abstract for poster presentation, American Society of Pediatric Hematology Oncology 28th Annual Meeting, Phoenix, AZ.
  • South G, Lee-Miller C, Hayes K, Eisenman K, Rogers A and Giller R. 2015. Single institution experience using allogeneic HSCT to treat pediatric NK/T cell lymphoma. Abstract for poster presentation, American Society of Pediatric Hematology Oncology 28th Annual Meeting, Phoenix, AZ.
  • Rogers AE, Eisenman KM, Dolan SA, Belderson KM, Zauche JR, Tong S, Gralla J, Hilden JM, Wang M, Maloney KW, Dominguez SR. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report. Pediatr Blood Cancer. 2016 Sep 12. [Epub ahead of print] PubMed PMID: 27616655
  • Rogers AE, Eisenman KM, Dolan SA, Belderson KM, Zauche JR, Tong S, Gralla J, Hilden JM, Wang M, Maloney KW, Dominguez SR. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report. Pediatr Blood Cancer. 2017 Mar;64(3). PubMed PMID: 27616655
  • Ross S, Eisenman K, Maloney KW. Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report. J Pediatr Hematol Oncol. 2018 Aug 8. [Epub ahead of print] PubMed PMID: 30095692

Professional Memberships

  • American Society of Pediatric Hematology Oncology, Fellow Member
  • American Academy of Pediatrics (AAP), Fellow Member

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Hospital Affiliation
  • Children's Hospital Colorado

Center Affiliations

Specialty Information

Specialties
  • Pediatrics, Board Certification (2006)
  • Pediatric Hematology / Oncology
Conditions & Treatments
  • Blood / Lymphatic System - Blood Disorders
  • Blood / Lymphatic System
Clinical Interests
My clinical interest is in childhood leukemia and lymphoma and associated side effects and infections related to therapy.

Care Philosophy
I love pediatric oncology because I am often given the opportunity and privilege to offer hope during a time often tied to fear. I am grateful and honored that families place trust in me to help them to choose the most appropriate treatment for their child and to journey with them during the course of their treatment. Each family’s values and goals are unique and each child is an individual and I embrace the opportunity to better understand the child and their family and how I can best help them through and beyond cancer therapy.

Personal Interests
In my spare time, I enjoy family time with my husband and three children, church activities, and skiing and hiking in Colorado.